Bronte Capital Management Pty Ltd. - DECIBEL THERAPEUTICS INC ownership

DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 39 filers reported holding DECIBEL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Bronte Capital Management Pty Ltd. ownership history of DECIBEL THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$596,280
+25.4%
154,878
-1.6%
0.06%
+5.5%
Q1 2023$475,514
+145317.1%
157,455
-1.2%
0.06%
+34.1%
Q4 2022$327
-99.9%
159,405
-2.5%
0.04%
-41.4%
Q3 2022$566,000
-58.9%
163,547
-50.0%
0.07%
-11.4%
Q2 2022$1,378,000
+177.8%
327,094
+100.4%
0.08%
+88.1%
Q1 2022$496,000
-32.1%
163,224
+3.8%
0.04%
-12.5%
Q4 2021$731,000
-40.5%
157,216
-1.4%
0.05%
-46.7%
Q3 2021$1,229,000
-10.4%
159,4620.0%0.09%
-8.2%
Q2 2021$1,371,000159,4620.10%
Other shareholders
DECIBEL THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ATLAS CAPITAL ADVISORS LLC 40,000$36,4000.01%
View complete list of DECIBEL THERAPEUTICS INC shareholders